Skip to main content
. 2020 Jun;21(6):1787–1795. doi: 10.31557/APJCP.2020.21.6.1787

Table 1.

Clinicopathological Characteristics of 207 HCC Patients with or without Cirrhosis

Clinicopathological characteristics Patients(n=207)
n %
Age ≤60 96 46.4
>60 111 53.6
BMI <25 94 45.4
≥25 103 49.8
Not reported 10 4.8
Race Non-Asian 121 58.5
Asian 80 38.6
Not reported 6 2.9
AFP ≤20ng/mL 109 52.7
>20ng/ml 76 36.7
Not reported 22 10.6
Gender Female 66 31.9
Male 141 68.1
Hepatitis B or C NO 94 45.4
YES 104 50.3
Not reported 9 4.3
Alcohol consumption NO 148 71.5
YES 50 24.2
Not reported 9 4.3
Cirrhosis status NO 130 62.8
YES 77 37.2
Histologic grade G1-2 133 64.2
G3-4 72 34.8
Not reported 2 1.0
New tumor event NO 97 46.9
YES 101 48.8
Not reported 9 4.3
Pathologic stage* Stage I+II 155 74.9
Stage III+IV 41 19.8
Not reported 11 5.3
Cancer status Tumor free 116 56
With tumor 84 40.6
Not reported 7 3.4
Family cancer history NO 111 53.6
YES 68 32.9
Not reported 28 13.5
Residual tumor R0 192 92.7
non-R0 13 6.3
Not reported 2 1.0
Vascular invasion Negative 138 66.7
Positive 60 29
Not reported 9 4.3

BMI, Body mass Index; AFP, Alpha fetoprotein; *TNM staging systems.